Pharma & Biotech
bit bio hopes to scale gene engineering platform opti-ox following rebrand
Silence Therapeutics looks to unlock further potential after 'transformational' year
Motif Bio PLC calls time on iclaprim
Only registered members can use this feature.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.